New research uncovers how superbug evades the immune system to cause infection

New research led by the University of Sheffield has discovered how a hospital superbug evades the immune system to cause infection - paving the way for new treatments.

The study, led by the University of Sheffield's Department of Molecular Biology and Biotechnology, investigated how Enterococcus faecalis (E. faecalis), bacteria commonly found in the digestive tracts of humans, cause life-threatening infections.

While E. faecalis is harmless in healthy carriers, it is also an opportunistic pathogen that frequently causes hospital-acquired infections such as heart valve infections, urinary tract infections and bacteremia - the presence of bacteria in the blood. Scientists currently do not fully understand how this happens.

Treatment of E. faecalis infection is difficult as it is highly resistant to several key components of the immune system and resistant to multiple antibiotics.

Now, new research led by Dr Stéphane Mesnage from the University of Sheffield's Department of Molecular Biology and Biotechnology, has discovered a mechanism used by E. faecalis to hide from the immune system of the host.

The study revealed that the bacteria changes a component of its cell surface in order to evade the immune system, enabling the spread of infection. The findings could pave the way for novel treatments for infections caused by E. faecalis.

Dr Stéphane Mesnage, Senior Lecturer in Molecular Biology and Biotechnology, said: "E. faecalis is an opportunistic pathogen. It is naturally resistant to a wide range of antibiotics including synthetic penicillin derivatives and is acquiring resistance to the last resort antibiotic vancomycin. Following an antibiotic treatment, E faecalis can out-compete other microorganisms to cause an infection.

"Our study shows that this organism modifies its polysaccharide surface, which is essential for causing an infection. Bacteria whose polysaccharides are unmodified are quickly recognized and engulfed by the cells of our immune system, whereas by modifying the polysaccharide, E. faecalis can evade the host immune cells and spread infection."

Dr Mesnage added: "Hospital-acquired infections caused by bacteria resistant to last resort antibiotics are on the rise. Our work suggests that targeting the mechanism that modifies the surface polysaccharides could be a novel strategy for developing new treatments to fight E. faecalis infections."

The research, Decoration of the enterococcal polysaccharide antigen EPA is essential for virulence, cell surface charge and interaction with effectors of the innate immune system, is published in the journal PLoS Pathogens.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study demonstrates safety of neural stem cell transplant for treating chronic spinal cord injury